Compass Therapeutics Announces $80M Private Placement
Compass Therapeutics, Inc. (NASDAQ:CMPX), ("Compass"), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that it has entered